Meta-analysis of 19 RCTs (1825 participants) in asthma: macrolides vs placebo improved asthma control (ACQ MD -0.23; 40.6% vs 21.6% reaching a meaningful gain) and likely cut severe exacerbations (IRR 0.75), with little to no effect on serious harms.
Meta-analysisn = 1,825
Ologundudu et al. Macrolides for asthma: A systematic review and meta-analysis of randomized trials